Table 2.

Episodes of Acute Cellular Rejection and Supplemental Immunosuppression in Grafts Surviving 30 Days

	Group 1	Group 2	Group 3	P Value
Number of primary grafts	109	34	36
Number of grafts with rejection in month 1	58 (53.2%)	21 (61.8%)	16 (44.4%)	NS
Onset of first episode (day)*	9.4 ± 0.8	8.8 ± 0.9	10.7 ± 2.1	NS
Number of rejection episodes
1	32 (29.4%)	12 (35.3%)	11 (30.6%)	NS
2	19 (17.4%)	8 (23.5%)	3 (8.3%)	NS
≥3	7 (6.4%)	1 (2.9%)	2 (5.6%)	NS
Supplemental immunosuppression
1 g methylprednisolone	0.55 ± 0.07†	0.97 ± 0.15	0.86 ± 0.13	.012
Steroid cycling	16 (14.7%)‡	11 (32.4%)	8 (22.2%)	.024
OKT3	4 (3.7%)	2 (5.9%)	0 (0%)	NS
T. Bilirubin at first month (mg/dL)	1.85 ± 0.29	1.26 ± 0.14	1.23 ± 0.17	NS

^*Biopsy verified, mean ± SE.

^†P = .012 vs group 2, P = .044 vs group 3.

^‡P = .024 vs group 2.